share_log

HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $15

Benzinga ·  Jun 5, 2023 06:15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $18 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment